The cellular mechanisms of spreading of pathological proteins, such as tau, α-synuclein, β-amyloid peptide (Aβ) and TDP-43, have been receiving increasing attention, and better understanding of the spreading mechanisms is expected to accelerate development of disease-modifying therapies for these devastating neurodegenerative diseases. This evidence concerns the gene MAPT and neurodegenerative disease.